Cargando…
Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort study
OBJECTIVE: To identify risk factors for functional decline after hospitalization for Gram-negative bacteremia. PATIENTS AND METHODS: A prospective cohort study based on a randomized controlled trial conducted between January 1, 2013 and August 31, 2017 in Israel and Italy. Hospitalized patients with...
Autores principales: | Turjeman, Adi, Koppel, Fidi, Franceschini, Erica, Yahav, Dafna, Dolci, Giovanni, Babich, Tanya, Bitterman, Roni, Neuberger, Ami, Ghanem-Zoubi, Nesrin, Santoro, Antonella, Eliakim-Raz, Noa, Pertzov, Barak, Stern, Anat, Dickstein, Yaakov, Maroun, Elias, Zayyad, Hiba, Meschiari, Marianna, Bishara, Jihad, Goldberg, Elad, Venturelli, Claudia, Mussini, Cristina, Paul, Mical, Leibovici, Leonard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598031/ https://www.ncbi.nlm.nih.gov/pubmed/34788325 http://dx.doi.org/10.1371/journal.pone.0259707 |
Ejemplares similares
-
Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial
por: Paul, Mical, et al.
Publicado: (2015) -
Piperacillin–tazobactam versus meropenem for treatment of bloodstream infections caused by third-generation cephalosporin-resistant Enterobacteriaceae: a study protocol for a non-inferiority open-label randomised controlled trial (PeterPen)
por: Bitterman, Roni, et al.
Publicado: (2021) -
Duration of antibiotic treatment for Gram-negative bacteremia – Systematic review and individual participant data (IPD) meta-analysis
por: Turjeman, Adi, et al.
Publicado: (2022) -
Excluded versus included patients in a randomized controlled trial of infections caused by carbapenem-resistant Gram-negative bacteria: relevance to external validity
por: Daitch, Vered, et al.
Publicado: (2021) -
Optimizing patient recruitment into clinical trials of antimicrobial-resistant pathogens
por: Paul, Mical, et al.
Publicado: (2023)